Presentation Information
[2P-231]The Therapeutic Potential of (R)-Carvedilol in Huntington’s Disease Through Enhancement of Autophagy-Lysosomal Pathway via GSK-3β Inhibition
*Tz Chuen Ju1,2, Chih Yuan Cheng3,4, Kai Po Chen1,3 (1. Institute of Molecular Biology, National Chung Hsing University, Taichung, Taiwan, 2. Doctoral Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan, 3. Department of Animal Science and Biotechnology, Tunghai University, Taichung, Taiwan, 4. Graduate Institute of Aerospace and Undersea Medicine, National Defense Medical Center, Taipei, Taiwan)
Keywords:
autophagy-lysosomal pathway (ALP),glycogen synthase 3β (GSK-3β),mutant huntingtin (mHTT),transcription factor binding to IGHM enhancer 3 (TFE3)
Abstract Password Authentication
A password is required to view the full text of the abstract. Please refer to the member site for the password.
https://membership.jnss.org/C00/login
https://membership.jnss.org/C00/login
Comment
To browse or post comments, you must log in.Log in
